Circularity Healthcare and the Professional Educational Research Institute have partnered to address the alarming health issues highlighted by the recent global pandemic lockdowns, specifically focusing on the epidemic of diabetic foot ulcers and associated amputations. Circularity’s primary focus is their unique use of D’OXYVA®, which has shown significant success in important pivotal human clinical trials.